510(k) Report

510(k) · Cleared

Cleared

Allofuse Plus

K103036510(k) TraditionalCleared Jan 10, 201189-day reviewClass II21 CFR 888.3045

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Allosource, Inc. · MQV Filler, Bone Void, Calcium Compound

Cleared on Jan 10, 2011 as substantially equivalent to K070751 (Isotis Orthobiologics, Inc., 2007) and 2 other predicates after an 89-day review. Its family tree reaches back 4 generations to 2004.

Decided
Jan 10, 2011
Review
89 days
Class
Class II
Product code
MQV
Recalls
None
Predicates
3

Its longest line of descent runs back 4 generations to K040980 (2004). 7 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 4 generations backK040980 Allomatrix C Putty, Allomatrix Custom Putty, Allomatrix DR Putty…Wrightmedicaltechnologyinc · 2004
  2. 3 generations backK040419 Dynagraft IIIsotis Orthobiologics, Inc. · 2005
  3. 2 generations backK050642 Orthoblast II Putty and PasteIsotis Orthobiologics, Inc. · 2005
  4. 1 generation backK070751 Orthoblast II DBM Demineralized Bone Matrix Paste and PuttyIsotis Orthobiologics, Inc. · 2007
  5. This deviceK103036 Allofuse PlusAllosource, Inc. · 2011
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K040980Allomatrix C Putty, Allomatrix Custom Putty, Allomatrix DR Putty, Ignite…Wrightmedicaltechnologyinc2004—
−3K040419Dynagraft IIIsotis Orthobiologics, Inc.2005—
−2K050642Orthoblast II Putty and PasteIsotis Orthobiologics, Inc.2005—
−1K070751Orthoblast II DBM Demineralized Bone Matrix Paste and PuttyIsotis Orthobiologics, Inc.2007—
0 (this device)K103036Allofuse PlusAllosource, Inc.2011—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200410
200510
200810
FIG. 1 — Lineage of K103036, 2004–2011Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K070751Orthoblast II DBM Demineralized Bone Matrix Paste and Putty
Summary page 1
…oid filler device (21 CFR 888.3045) MQV, MBP Predicate Device(s): Ortholast® it 510(k) # K070751, K050642 Allouse Gel and Putty 51 0(k)# K071 849 Device Description: Allouse P…
Isotis Orthobiologics, Inc.2007—
*K050642Orthoblast II Putty and Paste
Summary page 1
…r device (21 CFR 888.3045) MQV, MBP Predicate Device(s): Ortholast® it 510(k) # K070751, K050642 Allouse Gel and Putty 51 0(k)# K071 849 Device Description: Allouse Plus is de…
Isotis Orthobiologics, Inc.2005—
*K071849Allofuse Gel and Putty
Summary page 1
…redicate Device(s): Ortholast® it 510(k) # K070751, K050642 Allouse Gel and Putty 51 0(k)# K071 849 Device Description: Allouse Plus is derived from selected donated human bone tissue that has been processed into particles. The…
Allosource, Inc.20081

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 7 years and passes through 3 companies; a new generation was cleared every 1.9 years on median.
  • 2 of the 7 ancestors have a recall of any class.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

For orthopedic use, AlloFuse Plus Paste and Putty are intended for use as an autograft extender (i.e. extremities, posterolateral spine and pelvis) and as a bone void filler (i.e. extremities and pelvis) for bony voids or gaps that are not intrinsic to the stability of the bony structure. The AlloFuse Plus products are indicated to be packed gently into bony defects of the skeletal system. These defects may be surgically created or from the result of traumatic injury to the bone.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K103036: Allofuse Plus.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K103036

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026